Bank Of America Corp Lava Therapeutics Nv Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Bank Of America Corp holds 400 shares of LVTX stock, worth $660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 15,411
97.4%
Holding current value
$660
Previous $51,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.8MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.42 Million0.24% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.27 Million0.68% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$606,5100.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$185,5240.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$169,1250.04% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $42.6M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...